These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 37904560)
1. Dendrimers: Patents for Alzheimer's Disease. Maheshwari S; Singh A Recent Pat Nanotechnol; 2023 Oct; ():. PubMed ID: 37904560 [TBL] [Abstract][Full Text] [Related]
2. A Review of Brain-Targeted Nonviral Gene-Based Therapies for the Treatment of Alzheimer's Disease. Arora S; Sharma D; Layek B; Singh J Mol Pharm; 2021 Dec; 18(12):4237-4255. PubMed ID: 34705472 [TBL] [Abstract][Full Text] [Related]
3. PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia. Santos SD; Xavier M; Leite DM; Moreira DA; Custódio B; Torrado M; Castro R; Leiro V; Rodrigues J; Tomás H; Pêgo AP J Control Release; 2018 Dec; 291():65-79. PubMed ID: 30308255 [TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Preclinical Studies and Potential Applications of Dendrimers as Drug Carriers in the Central Nervous System. Gagliardi M Curr Pharm Des; 2017; 23(21):3105-3119. PubMed ID: 28294054 [TBL] [Abstract][Full Text] [Related]
6. Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity. Shao N; Su Y; Hu J; Zhang J; Zhang H; Cheng Y Int J Nanomedicine; 2011; 6():3361-72. PubMed ID: 22267921 [TBL] [Abstract][Full Text] [Related]
7. PAMAM Dendrimers Cross the Blood-Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice. Srinageshwar B; Peruzzaro S; Andrews M; Johnson K; Hietpas A; Clark B; McGuire C; Petersen E; Kippe J; Stewart A; Lossia O; Al-Gharaibeh A; Antcliff A; Culver R; Swanson D; Dunbar G; Sharma A; Rossignol J Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335421 [TBL] [Abstract][Full Text] [Related]
8. Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain. Beg S; Samad A; Alam MI; Nazish I CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):576-88. PubMed ID: 21631401 [TBL] [Abstract][Full Text] [Related]
9. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. Malik N; Wiwattanapatapee R; Klopsch R; Lorenz K; Frey H; Weener JW; Meijer EW; Paulus W; Duncan R J Control Release; 2000 Mar; 65(1-2):133-48. PubMed ID: 10699277 [TBL] [Abstract][Full Text] [Related]
11. Dendrimers and Derivatives as Multifunctional Nanotherapeutics for Alzheimer's Disease. Moreira DA; Santos SD; Leiro V; Pêgo AP Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111540 [TBL] [Abstract][Full Text] [Related]
12. Surface functionalisation regulates polyamidoamine dendrimer toxicity on blood-brain barrier cells and the modulation of key inflammatory receptors on microglia. Bertero A; Boni A; Gemmi M; Gagliardi M; Bifone A; Bardi G Nanotoxicology; 2014 Mar; 8(2):158-68. PubMed ID: 23298388 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review. Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973 [TBL] [Abstract][Full Text] [Related]
14. Use of Polyamidoamine Dendrimers in Brain Diseases. Florendo M; Figacz A; Srinageshwar B; Sharma A; Swanson D; Dunbar GL; Rossignol J Molecules; 2018 Sep; 23(9):. PubMed ID: 30177605 [TBL] [Abstract][Full Text] [Related]
15. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease. Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603 [TBL] [Abstract][Full Text] [Related]
17. Nanosize drug delivery system. Mukherjee B Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648 [TBL] [Abstract][Full Text] [Related]
18. Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease. Li L; Zhang J; Huang X; Du J; Tu Z; Wu H; Liu X; Yuan M Curr Pharm Des; 2023; 29(2):95-115. PubMed ID: 36529920 [TBL] [Abstract][Full Text] [Related]
19. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics. Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764 [TBL] [Abstract][Full Text] [Related]
20. Mixed Carboxyl and Hydrophobic Dendrimer Surface Inhibits Amyloid-β Fibrillation: New Insight from the Generation Number Effect. Wang Z; Dong X; Sun Y Langmuir; 2019 Nov; 35(45):14681-14687. PubMed ID: 31635460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]